Literature DB >> 23019494

Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42.

Naotaka Izuo1, Toshiaki Kume, Mizuho Sato, Kazuma Murakami, Kazuhiro Irie, Yasuhiko Izumi, Akinori Akaike.   

Abstract

The 42-mer amyloid β-protein (Aβ42) aggregates to form soluble oligomers that cause memory loss and synaptotoxicity in Alzheimer's disease (AD). Oxidative stress is closely related to the pathogenesis of AD. We previously identified the toxic conformer of Aβ42 with a turn at positions 22 and 23 ("toxic turn") by solid-state NMR and demonstrated that a monoclonal antibody (11A1) against the toxic turn in Aβ42 mainly detected the oligomer in the brains of AD patients. Our recent study suggested that oxidative stress is a key factor of the oligomerization and cognitive impairment induced by Aβ overproduction in vivo. However, the involvement of the toxic conformer in Aβ42-induced oxidative damage remains unclear. To investigate this mechanism, we examined the levels of intracellular reactive oxygen species (ROS) and neurotoxicity in rat primary neurons using E22P-Aβ42, a mutant that induces a turn at positions 22 and 23, and E22V-Aβ42, a turn-preventing mutant. E22P-Aβ42, but not E22V-Aβ42, induced greater ROS production than Wt-Aβ42 in addition to potent neurotoxicity. Interestingly, the formation of the toxic conformer in both E22P-Aβ42 and Wt-Aβ42 probed by the 11A1 antibody preceded Aβ42-induced neurotoxicity. Trolox (a radical scavenger) and Congo red (an aggregation inhibitor) significantly prevented the neurotoxicity and intracellular ROS induced by E22P-Aβ42 and Wt-Aβ42, respectively. These results suggest that Aβ42-mediated toxicity is caused by the turn that favors toxic oligomers, which increase generation of ROS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019494      PMCID: PMC3447395          DOI: 10.1021/cn300033k

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  45 in total

1.  Intraneuronal Abeta42 accumulation in human brain.

Authors:  G K Gouras; J Tsai; J Naslund; B Vincent; M Edgar; F Checler; J P Greenfield; V Haroutunian; J D Buxbaum; H Xu; P Greengard; N R Relkin
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

3.  The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Authors:  Camilla A Hansson Petersen; Nyosha Alikhani; Homira Behbahani; Birgitta Wiehager; Pavel F Pavlov; Irina Alafuzoff; Ville Leinonen; Akira Ito; Bengt Winblad; Elzbieta Glaser; Maria Ankarcrona
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

Review 4.  The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease.

Authors:  Kazuma Murakami; Yuichi Masuda; Takuji Shirasawa; Takahiko Shimizu; Kazuhiro Irie
Journal:  Geriatr Gerontol Int       Date:  2010-07       Impact factor: 2.730

5.  Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo.

Authors:  Tomohiro Umeda; Takami Tomiyama; Naomi Sakama; Saya Tanaka; Mary P Lambert; William L Klein; Hiroshi Mori
Journal:  J Neurosci Res       Date:  2011-04-12       Impact factor: 4.164

6.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.

Authors:  Kazuma Murakami; Nakaba Murata; Yusuke Ozawa; Noriaki Kinoshita; Kazuhiro Irie; Takuji Shirasawa; Takahiko Shimizu
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  Alpha-tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons.

Authors:  Fumitaka Osakada; Asami Hashino; Toshiaki Kume; Hiroshi Katsuki; Shuji Kaneko; Akinori Akaike
Journal:  Neuropharmacology       Date:  2004-11       Impact factor: 5.250

9.  Dietary intake of antioxidants and risk of Alzheimer disease.

Authors:  Marianne J Engelhart; Mirjam I Geerlings; Annemieke Ruitenberg; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

Review 10.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

View more
  7 in total

Review 1.  Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.

Authors:  Kirsten L Viola; William L Klein
Journal:  Acta Neuropathol       Date:  2015-01-22       Impact factor: 17.088

2.  Rational Design of a Cu Chelator That Mitigates Cu-Induced ROS Production by Amyloid Beta.

Authors:  Suchitra Mitra; Kallol Talukdar; Pallavi Prasad; Sandeep K Misra; Shabana Khan; Joshua S Sharp; Jonah W Jurss; Saumen Chakraborty
Journal:  Chembiochem       Date:  2021-12-30       Impact factor: 3.461

3.  A Toxic Conformer of Aβ42 with a Turn at 22-23 is a Novel Therapeutic Target for Alzheimer's Disease.

Authors:  Naotaka Izuo; Chihiro Kasahara; Kazuma Murakami; Toshiaki Kume; Masahiro Maeda; Kazuhiro Irie; Koutaro Yokote; Takahiko Shimizu
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

4.  Mitochondrial ubiquitin ligase alleviates Alzheimer's disease pathology via blocking the toxic amyloid-β oligomer generation.

Authors:  Keisuke Takeda; Aoi Uda; Mikihiro Mitsubori; Shun Nagashima; Hiroko Iwasaki; Naoki Ito; Isshin Shiiba; Satoshi Ishido; Masaaki Matsuoka; Ryoko Inatome; Shigeru Yanagi
Journal:  Commun Biol       Date:  2021-02-12

5.  Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis.

Authors:  Kazuma Murakami; Maki Tokuda; Takashi Suzuki; Yumi Irie; Mizuho Hanaki; Naotaka Izuo; Yoko Monobe; Ken-Ichi Akagi; Ryotaro Ishii; Harutsugu Tatebe; Takahiko Tokuda; Masahiro Maeda; Toshiaki Kume; Takahiko Shimizu; Kazuhiro Irie
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

6.  Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques.

Authors:  Yusuke Kageyama; Atsushi Saito; Olga Pletnikova; Gay L Rudow; Yumi Irie; Yang An; Kazuma Murakami; Kazuhiro Irie; Susan M Resnick; David R Fowler; Lee J Martin; Juan C Troncoso
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

7.  Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.

Authors:  Chihiro Akiba; Madoka Nakajima; Masakazu Miyajima; Ikuko Ogino; Yumiko Motoi; Kaito Kawamura; Satoshi Adachi; Akihide Kondo; Hidenori Sugano; Takahiko Tokuda; Kazuhiro Irie; Hajime Arai
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.